Please assess the completion status of the following clinical trial:

Trial Title: Color Doppler Analysıs Of Uterin And Intraovarian Blood Flow Before And After Treatment Wıth Cabergoline In Hyperprolactinemic Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Women who had blood prolactin level higher than 25ng/dl~Exclusion Criteria:~* Pregnancy~* Use of drugs effecting vasculature such as hormonal therapy, oral contraceptives, antihypertensives~* Diseases like pelvic inflammatory disease and systemic hypertension~* Women with clinically overt or treated cardiovascular disease~* Concurrent illness other than hyperprolactinemia

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- pretreatment group (Type: NO_INTERVENTION): doppler evaluation at pretreatment period
- posttreatment group (Type: EXPERIMENTAL): doppler evaluatıon in normoprolactinemia women who given cabergoline treatment

Based on this trial design, predict the completion outcome and termination type (if applicable).